Avience Biomedicals
OPENIPO Date: 18 Jun - 22 Jun 2026
Listing Date: 25 Jun 2026
Price Range
Rs.196 - Rs.208
Issue Size
30 Cr
Min Investment
₹1,17,600
Lot Size
600 Shares
Schedule of Avience Biomedicals
Issue open date
18 Jun 2026
Issue close date
22 Jun 2026
UPI mandate deadline
22 Jun 2026 (5 PM)
Allotment finalization
23 Jun 2026
Share credit
24 Jun 2026
Listing date
25 Jun 2026
Mandate end date
7 Jul 2026
Issue size
| Funds Raised in the IPO | Amount |
|---|---|
| Overall | 30 Cr |
| Fresh Issue | 30.24 Cr |
| Offer for Sale | 0 Cr |
Allotment DetailsNew
| Allotment Timeline | Details |
|---|---|
| Allotment Date | 23 Jun 2026 |
| Allotment Link | {Link} |
Grey Market PremiumNew
Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.
| Date | Ipo Price | GMP | Estimated Listing Price |
|---|---|---|---|
| 18 Jun 2026 | ₹208 | ₹75 | ₹283 (36.06%) |
| 17 Jun 2026 | ₹208 | ₹75 | ₹283 (36.06%) |
| 16 Jun 2026 | ₹208 | ₹63 | ₹271 (30.29%) |
| 15 Jun 2026 | ₹208 | ₹70 | ₹278 (33.65%) |
| 14 Jun 2026 | ₹208 | ₹0 | ₹208 (0%) |
| 13 Jun 2026 | ₹208 | ₹0 | ₹208 (0%) |
Performance Avience Biomedicals
| Issue Price | Listing Gain | Current Market Price | P/L |
|---|---|---|---|
| Rs.196 - Rs.208 | .... | .... | .... |
About Avience Biomedicals
Avience Biomedicals Limited is a medical consumables company that manufactures in vitro diagnostic (IVD) products and medical devices. The company’s product portfolio includes diagnostic kits for diseases such as COVID-19, HIV, malaria, dengue, and HBsAg, as well as serology products, biochemistry analysers, biochemistry reagents, culture media, and other medical consumables. In addition to manufacturing, the company also operates as a distributor and trader of medical equipment. Its products are supplied to pathology laboratories, microbiology laboratories, hospitals, research centres, government organisations, and distributors across India, and some exports too. Avience Biomedicals operates its manufacturing facility in Noida, Uttar Pradesh. This unit is equipped for the production of diagnostic kits, reagents, analysers, and related healthcare products. The company also has its registered office in New Delhi and has been allotted land in the Medical Device Park in the Yamuna Expressway Industrial Development Area, Uttar Pradesh.
| Founded in | 2019 |
| Managing director | Mr Dharam Deo Choudhary |
| Parent organization |
Financial Overview
Strengths
- Manufactures a wide range of diagnostic kits, medical devices, analysers and reagents.
- Serves pathology labs, hospitals, research centres and other healthcare institutions.
- Holds ISO 9001, ISO 13485, GMP and ZED MSME Gold certifications.
- Operates a manufacturing facility in Noida with advanced processing capabilities.
- Has expanded from diagnostic kits to a broader portfolio of healthcare products.
Risks
- Business performance may be affected by changes in government policies and regulations.
- Operations depend on the continued services of key management personnel and employees.
- The company relies on third-party transportation and logistics providers.
- Market demand and industry fluctuations can impact revenue and profitability.
- The company has ongoing legal proceedings involving commercial and cheque dishonour matters.
Subscription Figures
| Category | Subscription (No. of times) |
|---|---|
| Qualified Institutional Buyers (QIBs) | N/A |
| Non-Institutional Investors (NIIs) | 13.49 |
| Retail Individual Investors (RIIs) | 15.69 |
| Employee | N/A |
| Total | 10.75 |